Skip to main content
. 2021 Sep 29;9(10):1357. doi: 10.3390/biomedicines9101357

Figure 3.

Figure 3

Boxplots representing the distribution of lesion volumes calculated for (a) the expert-segmented follow-up lesions, separated by the treatment outcome of the patient, (b) the predicted follow-up lesion, separated by predicted treatment outcomes. Recanalization outcomes are abbreviated IAR (intra-arterial therapy, recanalizing), IVR (intravenous tPA, recanalizing), and NR (non-recanalizing). Significance markers (***) represent p < 0.001 for post-hoc tests following the one-way ANOVA performed in (a) and the one-way repeated-measures ANOVA performed in (b). Circular markers represent outliers with values more than 1.5 times the interquartile range.